Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.

Reduced fitness of HIV-1 resistant to CXCR4 antagonists.
Influence of human immunodeficiency virus type 1 subtype on mother-to-child transmission.
Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene Study.
HIV-1 resistance to the gp41-dependent fusion inhibitor C-34.
New antiretroviral drugs and approaches to HIV treatment.
Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trial.
Interleukin-7-dependent production of RANTES that correlates with human immunodeficiency virus disease progression.
HIV protease inhibitors and dyslipidemia.
Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.
Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression.